Skip to Content
Synthetic biology page header imageSynthetic biology page header image

Engineering biology

capgemini-invent

Advances in Engineering Biology, or synthetic biology, are unlocking a new industrial revolution in ‘AI for Science’ to address economic, environmental, and societal needs

What is Engineering biology? Engineering Biology is an emerging discipline of biotechnology with disruptive potential across all industries – whether addressing the climate crisis through biodegradable products and novel strategies for re-capturing carbon, or enabling new drugs and therapies that unlock unparalleled levels of personalized medicine.

Also known as ‘synthetic biology,’ engineering biology leverages the latest forms of Generative and Agentic AI, with other innovative technologies and engineering principles, to radically reduce the time and cost of realizing biotech solutions. From life sciences to manufacturing, pharmaceuticals to consumer goods, the applications for engineering biology are helping leading organizations realize truly disruptive and awe-inspiring ways to enhance their businesses.

At Capgemini Invent, over the past decade we have built a highly unusual set of scientific, engineering, computational and advisory skills to help clients navigate the E2E process of identifying, creating and launching new Biosolutions.

“From practical biological development to scale-up engineering and advisory services, our biotech experts can help your business realize sustainable, lasting transformation through engineering biology methods and solutions, through the entire E2E process.”

Applications of engineering biology

Across all industries, synthetic biology is changing the world in new and powerful ways.

Pharmaceuticals & medicine

Enabling new forms of advanced drug discovery and antibody production, tissue engineering, gene therapies, and diagnostics for more effective healthcare

Enabling the production of new and more sustainable biofuels like biodiesel and bioethanol that can reduce dependence on fossil fuels

Creating alternative solutions for materials like packaging, fabrics, and plastics, together with chemicals and ingredients, in areas like fertilizers, detergents, fragrances, and solvents with more sustainable footprints

Creating higher performance crops with more sustainable production and the ability to grow synthetic food and proteins in labs

Capturing carbon in new ways, creating biosensors that alert to the presence of pollutants, and offering approaches to clean/purify resources and chemical waste

How we can help: accelerating your bioeconomy journey

At Capgemini Invent we help clients successfully navigate the end-to-end journey, from creating a compelling new biotechnology vision, to practical breakthrough product realization and commercial impact.

We guide visionary start-ups and large multinationals alike in creating and implementing a bioeconomy strategy. Our expertise spans ‘engineered’ synthetic biology, protein synthesis, metabolic engineering, physical scale-up engineering, digital twinning and AI. Facilities include state-of-the-art, AI-driven biotechnology labs, engineering facilities, and a server farm to solve the toughest technical and scientific challenges.

Additionally, our biotech consultants will help you explore opportunities, build business and sustainability cases, test feasibility, and manage your innovation budget and timescale for highest business impact.

Engineering Biology labs

Building on 10 years of pioneering engineering biology and AI development, Capgemini has created state-of-the-art AI-driven biotechnology labs, situated at the headquarters of subsidiary, Cambridge Consultants, in the UK. Home to an unrivalled combination of multidisciplinary experts across biology, chemistry, engineering, data science and beyond, we have created innovative biosolutions such as a ‘plastic eating enzyme’, a DNA-based data storage machine and engineered nitrogen-fixing microbes for better seed shelf-life in agriculture. With deep synthetic biology expertise, we are particularly adept at making bio-engineering more predictable, and hence unlocking viable business cases in sectors ranging from healthcare, through to consumer and industrial.

With our engineering biology lab and deep industry expertise, we are uniquely placed to help clients identify new opportunities, reduce cost and time to accelerate their bio-journey.

Engineering biology

For more information about how you can implement Engineering or Synthetic Biology to gain a competitive advantage, please fill out the form below and one of our biotechnology experts will be in touch.

Demystifying Engineering Biology featured image

Future of Engineering Biology: Trust matters

There’s a crucial need to demystify bio-engineering solutions to demonstrate their value, gain public trust and understanding, and drive adoption and economic growth.

Accelerating the tech-driven bioeconomy

Explore our whitepaper on accelerating the tech-driven bioeconomy in collaboration with the World Economic Forum and published on their site

WEF Report Accelerating the Tech Driven BioEconomy book final version

Client stories

Meet our experts

synthetic biology

Richard Traherne

Head of Synthetic Biology and Next Frontiers at Capgemini Invent

Frances Metcalfe

Global head of Biotechnology at Cambridge Consultants, part of Capgemini Invent

Ian Taylor

Engineering Biology Expert at Cambridge Consultants, part of Capgemini Invent

Will Addison

Group Leader, AI, and Algorithms at Cambridge Consultants, part of Capgemini Invent

Sriya Mohanti

Sustainability Advisory at Capgemini Invent

Vishal Sanchania

Commercial director, Biotechnology at Cambridge Consultants, part of Capgemini Invent